Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-50 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-50 |
filingDate |
1993-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_152d429d079ab74fea07349b988ebb29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70545674683613c21c921d1e5ac8acce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1c278ef760d5a178cf456460134e858 |
publicationDate |
1994-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2101878-A1 |
titleOfInvention |
Platelet increasing-agent |
abstract |
TITLE: PLATELET INCREASING AGENT ABSTRACT A method of increasing platelets in mammals which comprises administering to mammals an effective amount of a heparin-binding secretory transforming factor 1 protein (hst-1) or a deletion type mutein. The heparin-binding secretory transforming factor (hst-1) or a mutein thereof can be used effectively with anti-tumor agents. |
priorityDate |
1992-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |